Transthyretin (TTR) amyloid cardiomyopathy
Clinical trials for Transthyretin (TTR) amyloid cardiomyopathy explained in plain language.
Never miss a new study
Get alerted when new Transthyretin (TTR) amyloid cardiomyopathy trials appear
Sign up with your email to follow new studies for Transthyretin (TTR) amyloid cardiomyopathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver clues: a new way to stage heart amyloidosis?
Knowledge-focused Recruiting nowThis study looks at whether liver function and blood clotting tests can help doctors better understand and monitor cardiac transthyretin amyloidosis (ATTR-CA), a condition where abnormal protein builds up in the heart. Researchers will compare these tests in people with ATTR-CA a…
Matched conditions: TRANSTHYRETIN (TTR) AMYLOID CARDIOMYOPATHY
Sponsor: University of Messina • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Blood test may track heart disease treatment
Knowledge-focused Recruiting nowThis study is tracking 50 adults with a heart condition called ATTR-CM to see if medications like tafamidis or acoramidis lower harmful amyloid proteins in the blood over time. Researchers will take blood samples at several visits to measure these proteins. The goal is to find ou…
Matched conditions: TRANSTHYRETIN (TTR) AMYLOID CARDIOMYOPATHY
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC